Certara Inc
NASDAQ:CERT 4:00:00 PM EDT
| Market Cap (Intraday) | 2.58B |
| Current PE | N/A |
| Forward PE | 37.58 |
| 2yr Forward PE | 31.08 |
| 10-Day MA | $16.80 |
| 50-Day MA | $17.75 |
| 200-Day MA | $16.29 |
Certara Inc Stock, NASDAQ:CERT
100 Overlook Center, Suite 101, Princeton, New Jersey 08540
United States of America
Phone: +1.609.716.7900
Number of Employees: 1391
Description
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Princeton, NJ.